HOTH News and Press, Hoth Therapeutics Inc. From 09/20/22

Hoth Therapeutics Announces Partnership with Altasciences for Manufacturing HT-TBI for Traumatic Brain Injury and Stroke PR Newswire TBI is responsible for 2.8 million accidents and emergency department visits annually in the U.S. Global Acute Ischemic Stroke M...

Hoth Therapeutics mRNA Frame-Shifting Therapeutic, HT-004, Shows Potential to Reduce Lung Inflammation in Asthma and Allergy Disorders PR Newswire Treatment with HT-004 significantly reduced lung inflammation after ovalalbumin (OVA) challenge in an asthma and allergy m...

Presentation Times and Weblinks Released for Over 50 Presenting Companies Wednesday and Thursday, August 17-18, 2022 NEW YORK, NY / ACCESSWIRE / August 16, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day August Micro-Cap Confer...

Hoth Therapeutics Announces Pipeline Presentation at the 2022 Sidoti Investor Conference PR Newswire NEW YORK , Aug. 12, 2022 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced toda...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical, announced today proof-of-concept data recorded using cognitive and behavioral assessments in an Alzheimer’s disease mouse model (aged APP/PS1+/- mice), indicating that HT-ALZ has cognitive ther...

The nano-cap biopharma Hoth Therapeutics ( NASDAQ: HOTH ) jumped ~39% in the morning hours Tuesday after the company announced proof-of-concept data supporting its Alzheimer’s candidate HT-ALZ based on a mouse model. The chronic oral dosing of HT-ALZ over more t...

Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Cognitive Improvements in Alzheimer's Disease Mouse Model PR Newswire Chronic treatment with HT-ALZ (>5 weeks) demonstrated significant improvement in behavioral and cognitive function tests in an Alzheimer's dise...

Nasdaq has granted Hoth Therapeutics ( NASDAQ: HOTH ) an additional 180-days or until December 26, 2022 to regain compliance with minimum $1.00 closing bid price per share requirement. In a letter dated December 30, 2021, the co...

Hoth Therapeutics Granted 180 Day Extension by Nasdaq to Regain Compliance with Bid Price Rule PR Newswire NEW YORK , June 29, 2022 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH) ("Hoth" or the "Company") today announced that the Company received ...

3 Tips for Buying Penny Stocks in July If you’re thinking about buying penny stocks in 2022, there is a lot to know. As traders, it is our job to find the best penny stocks to buy and study them. We need to understand current trends, global market conditions that may effect t...